[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, Tocilizumab (Actemra) is a humanized monoclonal antibody that binds to the interleukin-6 receptor (IL-6R) and blocks IL-6 signaling. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]